TABLE 2.
Variable | Category | Overall survival | Progression‐free survival | ||||
---|---|---|---|---|---|---|---|
Hazard ratio | 95% CI | p‐value | Hazard ratio | 95% CI | p‐value | ||
Age (y/o) | ≥60 | 1.46 | 0.74‐2.86 | 0.277 | 1.07 | 0.69‐1.67 | 0.765 |
Gender | Men | 1.81 | 0.89‐3.68 | 0.101 | 1.27 | 0.83‐1.96 | 0.275 |
ISS | ≥2 | 1.48 | 0.75‐2.91 | 0.264 | 1.62 | 1.02‐2.59 | 0.043 |
PS | ≥2 | 0.29 | 0.08‐1.01 | 0.052 | 0.80 | 0.43‐1.48 | 0.474 |
M protein | IgG | 0.55 | 0.28‐1.10 | 0.090 | 0.83 | 0.52‐1.31 | 0.415 |
Maintenance | + | 0.92 | 0.46‐1.82 | 0.807 | 0.70 | 0.45‐1.08 | 0.106 |
Note: An ISS ≥2 predicted worse PFS, while other factors failed to predict OS and PFS.
Abbreviations: CI, confidence interval; ISS, International Staging System; OS, overall survival; PFS, progression‐free survival; PS, performance status.